The estimated Net Worth of Erik Paulsen is at least $218 Thousand dollars as of 23 February 2022. Mr. Paulsen owns over 500 units of Cardiovascular Systems stock worth over $14,000 and over the last 5 years he sold CSII stock worth over $0. In addition, he makes $204,384 as Independent Director at Cardiovascular Systems.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Paulsen CSII stock SEC Form 4 insiders trading
Erik has made over 2 trades of the Cardiovascular Systems stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 500 units of CSII stock worth $9,525 on 23 February 2022.
The largest trade he's ever made was buying 500 units of Cardiovascular Systems stock on 23 February 2022 worth over $9,525. On average, Erik trades about 100 units every 79 days since 2019. As of 23 February 2022 he still owns at least 700 units of Cardiovascular Systems stock.
You can see the complete history of Mr. Paulsen stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Erik Paulsen biography
Erik Paulsen serves as Independent Director of the Company. Mr. Paulsen has been a member of our Board since July 2019. From 2009 to 2019, Mr. Paulsen represented Minnesota’s Third Congressional District in the United States House of Representatives. During his tenure, Mr. Paulsen was a leading member on the House Ways and Means Committee, the House’s tax-writing body with broad jurisdiction over healthcare, economic and trade policy. He also served as Chairman of Congress’ Joint Economic Committee, a unique House-Senate panel tasked with working alongside the President’s Council of Economic Advisors and the Federal Reserve Board to identify and address macroeconomic trends. Mr. Paulsen was co-chair of the bipartisan House Medical Technology Caucus, as well. Prior to his service in Congress, Mr. Paulsen was a member of the Minnesota State Legislature, where he served as House Majority Leader. Mr. Paulsen has over 16 years of business experience, including working as a business analyst at Target Corporation.
What is the salary of Erik Paulsen?
As the Independent Director of Cardiovascular Systems, the total compensation of Erik Paulsen at Cardiovascular Systems is $204,384. There are 15 executives at Cardiovascular Systems getting paid more, with Scott Ward having the highest compensation of $4,718,960.
How old is Erik Paulsen?
Erik Paulsen is 55, he's been the Independent Director of Cardiovascular Systems since 2019. There are 12 older and 13 younger executives at Cardiovascular Systems. The oldest executive at Cardiovascular Systems Inc. is Augustine Lawlor, 64, who is the Independent Director.
What's Erik Paulsen's mailing address?
Erik's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.
Insiders trading at Cardiovascular Systems
Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.
What does Cardiovascular Systems do?
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
What does Cardiovascular Systems's logo look like?
Complete history of Mr. Paulsen stock trades at Cardiovascular Systems
Cardiovascular Systems executives and stock owners
Cardiovascular Systems executives and other stock owners filed with the SEC include:
-
Scott Ward,
Chairman of the Board, President, Chief Executive Officer -
Rhonda Robb,
Chief Operating Officer -
Scott Raymond Ward B.Sc., M.S., MS,
Chairman, Pres & CEO -
Scott Raymond Ward M.S., MS, B.Sc.,
Chairman, Pres & CEO -
Jeffrey Points,
Chief Financial Officer -
Alexander Rosenstein,
General Counsel and Corporate Secretary -
Ryan Egeland,
Chief Medical Officer -
Rhonda J. Robb,
Chief Operating Officer -
Sandra Sedo,
Chief Compliance Officer -
Jeffrey S. Points,
Chief Financial Officer -
Alexander Rosenstein,
Gen. Counsel & Corp. Sec. -
Dr. Ryan D. Egeland M.D., Ph.D.,
Chief Medical Officer -
Edward Brown,
Independent Director -
Augustine Lawlor,
Independent Director -
Martha Aronson,
Independent Director -
Erik Paulsen,
Independent Director -
William Cohn,
Independent Director -
Stephen Stenbeck,
Independent Director -
Stephen Rempe,
Chief Human Resource Officer -
Kelvin Womack,
Independent Director -
David Whitescarver,
Vice President - Corporate Development and Intellectual Property -
John Hastings,
Vice President - Manufacturing and Operations -
Stephen J. Rempe,
Chief HR Officer -
David S. Whitescarver,
VP of Corp. Devel. & Intellectual Property -
Sandra M. Sedo,
Chief Compliance Officer -
John M. Hastings,
Exec. VP of Operations & Technology -
John E. Nielsen,
VP of Investor Relations & Corp. Communications -
Brent G Blackey,
Director -
Leslie Trigg,
Director -
Capital Management Lp Camber,
10% owner -
Scott A Bartos,
Director -
Laurence L Betterley,
Chief Financial Officer -
Kevin J. Kenny,
Chief Operating Officer -
Laura Gillund,
Chief Talent Officer -
Sachin H. Jain,
Director -
Capital Ltdmaverick Capital...,
-
Gary M Petrucci,
Director -
Paul A. Koehn,
SVP Quality & Operations -
James E Flaherty,
Chief Administrative Officer -
Glen D Nelson,
Director -
Robert J Thatcher,
Executive VP -
David Martin,
President and CEO -
Geoffrey O Hartzler,
Director -
Brian Doughty,
VP of Marketing -
Paul A Tyska,
VP of Business Dev -
Roger J Howe,
Director -
Group I, Llc Donoghue Danie...,
-
John H Friedman,
Director -
Scott William Kraus,
VP Sales -
Advisors, Inc Bonderman Dav...,
-
Geoffrey M Duyk,